Martino Steven C, Elliott Marc N, Cleary Paul D, Kanouse David E, Brown Julie A, Spritzer Karen L, Heller Amy, Hays Ron D
RAND, Pittsburgh, PA 15213-2665, USA.
Health Care Financ Rev. 2009 Spring;30(3):41-53.
Using data from 335,249 Medicare beneficiaries who responded to the 2007 Medicare Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey, along with data from 22 cognitive interviews, we investigated the reliability and validity of an instrument designed to assess beneficiaries' experiences with their prescription drug plans. Composite measures derived from the instrument had acceptable internal consistency and sufficient plan-level reliability to inform consumer choice, quality improvement, and payor oversight. These measures were positively associated with members' overall rating of the plan and their willingness to recommend the plan. Moreover, each was independently useful in predicting beneficiaries' global ratings of their plan. This instrument can be an important tool for helping beneficiaries to choose a plan that best meets their needs.
我们使用了335,249名回应2007年医疗保险医疗服务提供者和系统消费者评估（CAHPS）调查的医疗保险受益人的数据，以及22次认知访谈的数据，来调查一种旨在评估受益人在其处方药计划方面体验的工具的可靠性和有效性。从该工具得出的综合指标具有可接受的内部一致性和足够的计划层面可靠性，可为消费者选择、质量改进和付款方监督提供信息。这些指标与成员对计划的总体评分及其推荐该计划的意愿呈正相关。此外，每个指标在预测受益人对其计划的总体评分方面都具有独立的作用。该工具可以成为帮助受益人选择最符合其需求的计划的重要工具。
